CD4⁺ T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells–novel implications of CD4⁺ T cells in pancreatic cancer development

References

• Siegel R, Naishadham D, Jemal, A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11-30; PMID:23335087; http://dx.doi.org/10.3322/caac.21166
   PubMed Web of Science ®Google Scholar
• Schneider G, Siveke JT, Eckel F, Schmid RM. Pancreatic cancer: basic and clinical aspects. Gastroenterology 2005; 128:1606-25; PMID:15887154; http://dx.doi.org/10.1053/j.gastro.2005.04.001
   PubMed Web of Science ®Google Scholar
• Kleeff J, Beckhove P, Esposito I, Herzig S, Huber PE, Löhr JM, Friess H. Pancreatic cancer microenvironment. Int J Cancer 2007; 121:699-705; PMID:17534898; http://dx.doi.org/10.1002/ijc.22871
   PubMed Web of Science ®Google Scholar
• Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki M, Kosuge T, Kanai Y, Hiraoka N. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer 2013; 108:914-23; PMID:23385730; http://dx.doi.org/10.1038/bjc.2013.32
   PubMed Web of Science ®Google Scholar
• Protti MP, De Monte L. Immune infiltrates as predictive markers of survival in pancreatic cancer patients. Front Physiol 2013; 4:210; PMID:23950747; http://dx.doi.org/10.3389/fphys.2013.00210
   PubMed Web of Science ®Google Scholar
• Helm O, Mennrich R, Petrick D, Goebel L, Freitag-Wolf S, Röder C, Kalthoff H, Röcken C, Sipos B, Kabelitz D et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. Plos One 2014; 9:e94357; PMID:24797069; http://dx.doi.org/10.1371/journal.pone.0094357
   PubMed Web of Science ®Google Scholar
• Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005; 5:263-74; PMID:15776005; http://dx.doi.org/10.1038/nrc1586
   PubMed Web of Science ®Google Scholar
• Fogar P, Basso D, Fadi E, Greco E, Pantano G, Padoan A, Bozzato D, Facco M, Sanzari MC, Teolato S et al. Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle. Pancreas 2011; 40:1131-37; PMID:21792088; http://dx.doi.org/10.1097/MPA.0b013e31822077b8
   PubMedGoogle Scholar
• Bonde AK, Tischler V, Kumar S, Soltermann A, Schwendener RA. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer 2012; 12:35; PMID:22273460; http://dx.doi.org/10.1186/1471-2407-12-35
   PubMed Web of Science ®Google Scholar
• Lin CY, Lin CJ, Chen KH, Wu JH, Huang SH, Wang SM. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. FEBS Lett 2006; 580:3042-50; PMID:16678166; http://dx.doi.org/10.1016/j.febslet.2006.04.049
   PubMed Web of Science ®Google Scholar
• Helm O, Held-Feindt J, Grage-Griebenow E, Reiling N, Ungefroren U, Vogel I, Krüger U, Becker T, Ebsen M, Röcken C et al. Tumor associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis. Int J Cancer 2014; 135:843-61; PMID:24458546; http://dx.doi.org/10.1002/ijc.28736
   PubMed Web of Science ®Google Scholar
• Geismann C, Morscheck M, Koch D, Bergmann F, Ungefroren H, Arlt A, Tsao MS, Bachem MG, Altevogt P, Sipos B et al. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res 2009; 69:4517-26; PMID:19435915; http://dx.doi.org/10.1158/0008-5472.CAN-08-3493
   PubMed Web of Science ®Google Scholar
• Sebens Muerkoster S, Werbing V, Sipos B, Debus MA, Witt M, Grossmann M, Leisner D, Kötteritzsch J, Kappes H, Klöppel G et al. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 2007; 26:2759-68; PMID:17086212; http://dx.doi.org/10.1038/sj.onc.1210076
   PubMed Web of Science ®Google Scholar
• Schäfer H, Geismann C, Heneweer C, Egberts JH, Korniienko O, Kiefel H, Moldenhauer G, Bachem MG, Kalthoff H, Altevogt P et al. Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent. Carcinogenesis 2012; 33:84-93; PMID:22095073; http://dx.doi.org/10.1093/carcin/bgr262
   PubMed Web of Science ®Google Scholar
• Ben Q-W, Wang J-C, Liu J, Zhu Y, Yuan F, Yao W-Y, Yuan Y-Z. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol 2010; 17:2213-21; PMID:20162456; http://dx.doi.org/10.1245/s10434-010-0955-x
   PubMed Web of Science ®Google Scholar
• Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, Sakoda M, Ueno S, Natsugoe S, Takao S. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 2009; 167:e211-19; PMID:19765725; http://dx.doi.org/10.1016/j.jss.2009.05.026
   PubMedGoogle Scholar
• Kurahara H, Takao S, Maemura K, Mataki Y, Kuwahata T, Maeda K, Sakoda M, Iino S, Ishigami S. M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas 2013; 42:155-59; PMID:22699204; http://dx.doi.org/10.1097/MPA.0b013e318254f2d1
   PubMedGoogle Scholar
• Hiraoka N, Onozato K, Kosuge T, Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 2006; 12:5423-34; PMID:17000676; http://dx.doi.org/10.1158/1078-0432.CCR-06-0369
   PubMed Web of Science ®Google Scholar
• Ikemoto T, Yamaguchi T, Morine Y, Imura S, Soejima Y, Fujii M, Maekawa Y, Yasutomo K, Shimada M. Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients. Pancreas 2006; 33:386-90; PMID:17079944; http://dx.doi.org/10.1097/01.mpa.0000240275.68279.13
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-54; PMID:12189386; http://dx.doi.org/10.1038/nrc822
   PubMed Web of Science ®Google Scholar
• Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012; 148:349-61; PMID:22265420; http://dx.doi.org/10.1016/j.cell.2011.11.025
   PubMed Web of Science ®Google Scholar
• Rhim AD, Thege FI, Santana SM, Lannin TB, Saha TN, Tsai S, Maggs LR, Kochman ML, Ginsberg GG, Lieb JG et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology 2014; 146:647-51; PMID:24333829; http://dx.doi.org/10.1053/j.gastro.2013.12.007
   PubMed Web of Science ®Google Scholar
• Liu N, Furukawa T, Kobari M, Tsao MS. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am J Pathol 1998; 153:263-69; PMID:9665487; http://dx.doi.org/10.1016/S0002-9440(10)65567-8
   PubMed Web of Science ®Google Scholar
• Ouyang H, Mou L, Luk C, Liu N, Karaskova J, Squire J, Tsao MS. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol 2000; 157:1623-31; PMID:11073822; http://dx.doi.org/10.1016/S0002-9440(10)64800-6
   PubMed Web of Science ®Google Scholar
• Grage-Griebenow E, Jerg E, Gorys A, Wicklein D, Wesch D, Freitag-Wolf S, Goebel L, Vogel I, Becker T, Ebsen M et al. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression. Mol Oncol 2014; 8:982-97; PMID:24746181; http://dx.doi.org/10.1016/j.molonc.2014.03.001
   PubMed Web of Science ®Google Scholar
• Limame R, Wouters A, Pauwels B, Fransen E, Peeters M, Lardon F, De Wever O, Pauwels P. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One 2012; 7:e46536; PMID:23094027; http://dx.doi.org/10.1371/journal.pone.0046536
   PubMed Web of Science ®Google Scholar
• Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC, Manjili MH et al. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 2009; 69:2887-95; PMID:19276366; http://dx.doi.org/10.1158/0008-5472.CAN-08-3343
   PubMed Web of Science ®Google Scholar
• Wang H, Wang HS, Zhou BH, Li CL, Zhang F, Wang XF, Zhang G, Bu XZ, Cai SH, Du J. Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer. PLoS One 2013; 8:e56664; PMID:23431386; http://dx.doi.org/10.1371/journal.pone.0056664
   PubMed Web of Science ®Google Scholar
• Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL, Chao CH, Yamaguchi H, Yang NK, Ding Q et al. Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. Cancer Res 2012; 72:1290-300; PMID:22253230; http://dx.doi.org/10.1158/0008-5472.CAN-11-3123
   PubMed Web of Science ®Google Scholar
• Techasen A, Namwat N, Loilome W, Duangkumpha K, Puapairoj A, Saya H, Yongvanit P. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. J Hepatobiliary Pancreat Sci 2014 May 27; 21(9):703-11 [Epub ahead of print]; PMID:24867797; http://dx.doi.org/10.1002/jhbp.125
   PubMedGoogle Scholar
• Chua HL1, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 2007; 26:711-24; PMID:16862183; http://dx.doi.org/10.1038/sj.onc.1209808
   PubMed Web of Science ®Google Scholar
• Egberts JH, Cloosters V, Noack A, Schniewind B, Thon L, Klose S, Kettler B, von Forstner C, Kneitz C, Tepel J et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2008; 68:1443-50; PMID:18316608; http://dx.doi.org/10.1158/0008-5472.CAN-07-5704
   PubMed Web of Science ®Google Scholar
• Grage-Griebenow E, Schäfer H, Sebens S. The fatal alliance of cancer and T cells: how pancreatic tumor cells gather immunosuppressive T cells. OncoImmunology 2014; 25:e29382; PMID:25114835; http://dx.doi.org/10.4161/onci.29382
   PubMedGoogle Scholar
• Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124:263-6; PMID:16439202; http://dx.doi.org/10.1016/j.cell.2006.01.007
   PubMed Web of Science ®Google Scholar
• Rivera LB, Bergers G. Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity. Cancer Cell 2013; 24:687-9; PMID:24332035; http://dx.doi.org/10.1016/j.ccr.2013.11.014
   PubMedGoogle Scholar
• Bergmann F, Wandschneider F, Sipos B, Moldenhauer G, Schniewind B, Welsch T, Schirrmacher P, Klöppel G, Altevogt P, Schäfer H et al. Elevated L1CAM expression in precursor lesions and primary and metastatic tissues of pancreatic ductal adenocarcinoma. Oncol Rep 2010; 24:909-15; PMID:20811670; http:dx.doi.org/10.1038/onc.2012.44.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yan W, Mathew E, Bednar F, Wan S, Collins MA, Evans RA, Welling TH, Vonderheide RH, di Magliano MP. CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice. Cancer Immunol Res 2014; 2:423-35; PMID:24795355; http://dx.doi.org/10.1158/2326-6066.CIR-14-0016-T
   PubMedGoogle Scholar
• Zhang Y, McAllister F, di Magliano MP. Immune cells in pancreatic cancer. OncoImmunology 2014; 3:e29125; PMID:25083330; http://dx.doi.org/10.4161/onci.29125
   PubMedGoogle Scholar